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A B S T R A C T
Polymorphisms within the open reading frame as well as the promoter and regulatory regions can
inﬂuence the amount of CCR5 expressed on the cell surface and hence an individual’s susceptibility to
HIV-1. In this study we characterize CCR5 genes within the South African African (SAA) and Caucasian
(SAC) populations by sequencing a 9.2 kb continuous region encompassing the CCR5 open reading frame
(ORF), its two promoters and the 30 untranslated region. Full length CCR5 sequences were obtained for 70
individuals (35 SAA and 35 SAC) and sequences were analyzed for the presence of single-nucleotide
polymorphisms (SNPs), indels and intragenic haplotypes. A novel SNP (+258G/C) within the ORF leading
to a non-synonomous amino acid (Trp! Cys) change was detected in one Caucasian individual. Results
demonstrate a high degree of genetic variation: 68 SNP positions, four indels, as well as theD32 deletion
mutant, were detected. Seven complex putative haplotypes spanning the length of the sequenced region
have been identiﬁed. These haplotypes appear to be extensions of haplotypes previously described
within CCR5. Two haplotypes, SAA-HHE and SAC-HHE were found in high frequency in the SAA and SAC
population groups studied (20.0% and 18.6%, respectively) and share four SNP positions suggesting an
evolutionary link between the two haplotypes. Only one of the identiﬁed haplotypes, SAA/C–HHC, is
common to both study populations but the haplotype frequency differs markedly between the two
groups (8.6% in SAA and 52.9% in SAC). The two population groups show differences in both haplotype
arrangement as well as SNP proﬁle.
 2010 Elsevier B.V.
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The human coreceptor, CCR5, acts as the principal coreceptor
required for macrophage-tropic (R5) human immunodeﬁciency
virus type 1 (HIV-1) virions to gain entry to a cell (Deng et al., 1996;
Dragic et al., 1996). Shortly after the role of CCR5 was discovered,
the CCR5D32 mutant and its association with protection to HIV-1
infection in individuals homozygous for this allele, was found
(Samson et al., 1996). This discovery provided the ﬁrst genetic
evidence of protection to HIV-1 infection and prompted further
studies of the gene and how its naturally occurring mutations may
inﬂuence the outcome of HIV-1 exposure and infection.
The CCR5 gene is composed of four exons and two introns,
where exons 2A and 2B are not interrupted by an intron (Mummidi
et al., 1997). Exon 3 contains an intronless open reading frame
(ORF). Two CCR5 promoters have been described, a weak upstream* Corresponding author at: AIDS Virus Research Unit, National Institute for
Communicable Diseases, Private Bag X4, Sandringham, Johannesburg 2131, South
Africa. Tel.: +27 11 386 6365; fax: +27 11 386 6465.
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Open access under CC BY license.promoter (PU or P2) and a stronger downstream promoter (PD or
P1) (Mummidi et al., 1997). Cell surface expression of CCR5 is
highly variable, even in individuals homozygous for the wild type
ORF region. This may be explained by differences in the promoter
region of CCR5 which result in differing CCR5 expression levels
(Menten et al., 2002). To date, several mutations and single-
nucleotide polymorphisms (SNPs) in the HIV-1 coreceptor gene,
CCR5, have been found to be important genetic factors capable of
inﬂuencing susceptibility to HIV-1 infection or affecting the rate of
disease progression.
Striking ethnic or population differences in SNP frequencies of
CCR5 exist. The most studied polymorphism exhibiting this is the
CCR5D32 mutant. The CCR5D32 allele occurs at a variable
frequency of 4–15% in Caucasian populations, with an average
of 10% in Europe (reviewed in Galvani and Novembre, 2005) and
yet is rarely found in Asian or African populations. In a South
African context, Petersen et al. (2001) identiﬁed seven novel
mutations within the CCR5 ORF in African and Coloured popula-
tions, however polymorphisms within the promoter region have
not been studied. Thus, a detailed descriptive study of SNPs and/or
haplotypes within the CCR5 receptor gene was carried out in two
South African populations, South African Africans (SAA) and South
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study of the prevalence of polymorphisms that exist in CCR5within
these populations and to determinewhether all previously deﬁned
haplotypes are represented within these populations.
2. Materials and methods
2.1. Study population
Characterization of the CCR5 gene was carried out on 70
healthy, HIV-1 uninfected adult volunteers, 35 were SAA and 35
were SAC. This study was approved by the University of the
Witwatersrand Committee for Research on Human Subjects, and
informed written consent was obtained from all participants.
2.2. PCR and sequencing of CCR5
Genomic DNA was extracted from blood samples anticoagu-
lated with ethylenediaminetetraacetic acid (EDTA) using QIAamp
DNA Mini Kit (QIAGEN, Dusseldorf, Germany). A 9.2 kb con-
tinuous region encompassing the CCR5 open reading frame (ORF),
its two promoters and the 30 untranslated region (UTR) was
polymerase chain reaction (PCR) ampliﬁed in ﬁve overlapping
sections using Expand High Fidelity PCR System (Roche, Man-
nheim, Germany). PCR and sequencing primers were designed
using PRIMER DESIGNER for Windows (v. 2.0) (Supplementary
Table S1) using the published sequences for CCR5 (GenBank
accession: U95626, AF017632 (Moriuchi et al., 1997), AF031236
and AF031237 (Mummidi et al., 1997)) as reference sequences.
All sequencing reactions were carried out using BigDye
Terminator version 3.1 chemistry (Applied Biosystems, Foster
City, CA, USA). Ampliﬁed fragments were sequenced using the
automated 3100 Genetic Analyzer (Applied Biosystems).
2.3. Sequence analysis
Sequence data was assembled and analyzed for the presence of
SNPs and indels using SEQUENCHER software version 4.5 (Gene
Codes Corporation, Ann Arbor, MI, USA). Assembled sequences
were aligned with each other and the published GenBank
sequence, U95626, using SEQUENCHER, to identify polymorph-
isms. The GenBankNCBI SNP database (dbSNP)was searched for all
reported SNPs in the CCR5 gene to determine whether polymorph-
isms detected in this study had been previously reported.
The CCR5 numbering system used in this study is as described
by Mummidi et al. (2000) where the ﬁrst nucleotide of the
translational start site is designated as +1 and the nucleotide
immediately upstream from that is 1. A composite of the
reference sequences AF031236 and AF031237 (Mummidi et al.,
1997) was used as a basis for determining SNP positions as these
sequences appeared to be closer to the wild type (WT) or more
‘ancestral’ gene. It must be noted however that when all Homo
sapiens reference sequences used in this study were aligned, a
number of differences between them were noted, including base
insertions or deletions (indels), which would affect the SNP
position values. Also, AF031236 and AF031237 do not encompass
the entire region sequenced in our study. Thus, using the
sequences ﬂanking the various SNPs may be a more reliable
means of identifying SNP positions (Supplementary Table S2).
2.4. Determination of wild type (WT) reference sequence
Once polymorphisms within CCR5 were identiﬁed, it was
necessary to determine which nucleotide to deem as the WT
nucleotide. Generally, the most prevalent nucleotide in our
combined populations was considered to be the WT or ancestralnucleotide/allele. In addition, to identify the WT nucleotide where
it was not apparent which nucleotide/allele was most prevalent,
the human CCR5 sequences were aligned with those of the
chimpanzee found on the sequence available for Pan troglodytes
chromosome 3 (GenBank accession number: NW_001232822.1)
and the Pan troglodytes CCR5 sequence (GenBank accession
numbers: NM_001009046 and AF005663).
2.5. Inference of putative haplotypes
Analysis of the sequence data generated for CCR5 revealed
certain obvious patterns wherein the presence of a polymorphism
at one positionwas consistently associatedwith polymorphisms at
one or more other positions. These associations were identiﬁed as
putative intragene haplotypes. The HAPLOTYPER software which
uses a Bayesian algorithm for haplotypes inference (Niu et al.,
2002) was also used to infer haplotypes for CCR5.
The frequencies of putative intragenic haplotypes were
calculated by counting the number of alleles harbouring the
haplotypes and dividing by the total number of alleles. Counting of
the haplotypes was irrespective of the presence of additional SNPs
not forming part of the haplotypes in question.
2.6. Characterization of indels
Five SAA and one SAC individual appeared to have a previously
unidentiﬁed indel downstream from the open reading frame
(+2772). Characterization of the putative indel as well as
veriﬁcation of Intron 2 indels was carried out by TA cloning of
PCR amplicons into the pCR14-TOPO1 cloning vector using the
TOPO-TA Cloning Kit (Invitrogen, Carlsbad, CA, USA). Recombinant
plasmids were screened for the allele with the putative indel by
sequencing. Sequences were aligned with reference sequences,
using SEQUENCHER, in order to characterize the indel.
2.7. Hardy–Weinberg equilibrium
All polymorphic loci detected within the characterized CCR5
gene region were tested for deviation from Hardy–Weinberg
equilibrium using the conventional Monte Carlo exact test of Guo
and Thompson (1992) implemented through the computer
program TFPGA (Miller, 1997). The two population groups were
tested independently.
2.8. Linkage disequilibrium between haplotype SNPs
To test whether the SNPs forming part of the putative intragenic
haplotypes were in complete or strong linkage, linkage disequili-
brium between every two SNP combination in each haplotype was
estimated using the method described by Lewontin (1964) where
the linkage disequilibrium coefﬁcient D was calculated (Dij = H-
Fij  pipj). D was subsequently normalized (D0) or standardized by
the maximum value it can take (Dmax) using the formula D0ij = Dij/
Dmax where HFij is the frequency of the haplotypes carrying SNPs i
and j, pi and pj are the frequencies of SNPs i and j, respectively and
Dmax is either min [pipj, (1  pi)(1  pj) if Dij < 0, or min [(1  pi) pj,
pi(1  pj)] ifDij > 0.D0 values are deﬁned in the range [1, 1] with a
value of ‘1’ representing perfect disequilibrium. The statistical
signiﬁcance of the linkage disequilibrium between each of the SNP
pairs was evaluated by the approximate chi-square described by
Liau et al. (1984).
2.9. Fisher exact test
Fisher exact tests were performed using the Simple Interactive
StatisticalAnalysis software (Uitenbroek,D.G., Binomial. SISA. 1997.
Fig. 1. Schematic representation of CCR5 gene region sequences indicating polymorphism positions and nucleotide base changes at these points. The structure of the gene
(Mummidi et al., 1997) is indicated by colour coded boxes. Nucleotide base changes at SNP positions are described by stating theWT base ﬁrst followed by the base found on
the minor allele. Grey boxes delineate regions of the CCR5 gene which have been previously used to describe CCR5 haplotypes. Newly identiﬁed (NI) polymorphisms and
indels are indicated in bold font. UTR: untranslated region, ORF: open reading frame.
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htm. [1 January 2004]) to test whether there was any signiﬁcant
difference in SNP frequencies between this and other studies.
3. Results
3.1. Single-nucleotide polymorphisms
Assembled sequences of the CCR5 gene including promoter,
coding and 30 UTR regions, from 70 HIV-1 uninfected individuals
were analyzed for DNA polymorphisms, SNPs and indels. Across
the entire 9.2 kb region sequenced, 68 SNPs were identiﬁed. The
positions and nucleotide (nt) changes are indicated in Fig. 1. The
identiﬁed polymorphisms were found across the entire sequenced
region with the exclusion of exon 2B, a small region spanning 54
nucleotides. The majority of the polymorphisms were located in
the intron and UTR of the gene and only six were located in the ORF
(Fig. 1). With regards to the two study populations, 60 and 37
polymorphisms were found in the SAA and SAC populations,
respectively. Of the 68 identiﬁed SNPs, 46 have been previously
described in the GenBank dbSNP database and by Petersen et al.
(2001). Their corresponding accession numbers, where available,
are shown in Table 1. To the best of our knowledge, with
comparison to the GenBank dbSNP database and literature reports,
24 polymorphisms are newly identiﬁed and have been designated
as newly identiﬁed (NI) in Table 1. These NI polymorphisms were
found in both population groups. Newly identiﬁed polymorphisms
are also distributed across the entire gene although the majority
are located in the 50 and 30 UTRs. Most NI SNPs were found to be
rare polymorphisms present in only one individual. Exceptions to
this were the NI polymorphisms, 4223C/T, 3886C/T, 2454G/A
and 451C/T, which were detected in higher numbers (three or
four individuals each, all of which were heterozygous for the
polymorphisms) in either/both populations.
The alignment of reference sequences (GenBank accession
numbers: U95626, AF031236, AF031237, AF017632 and
NT_022517.17) did not demonstrate 100% homology at many of
the SNP positions detected, as well as at other potential
polymorphic positions not detected in this study. Also, it was
not always apparent which the most predominant base at certain
positionswas. For instance,with the2554G/T SNP, 79 (56.4%) and
61 (43.6%) alleles in this study contained a G and T nucleotide,
respectively. Although the G allele was more frequent overall, in
the SAC population themajor nucleotidewas a T (55.7%) and in SAA
individuals the major alleles was a G (68.6%). Caution was
necessary in the selection of a WT nucleotide as the populationsizes used in this study were of a size where bias could be
introduced and the apparent WT allele (most frequent) may not
correspond to the ancestral allele. Thus, reference Homo sapiens
sequences were aligned with Pan troglodytes sequences. Due to the
low mutation rate since the human–chimpanzee divergence, the
human allele almost always corresponds to the allele present in
chimpanzees (Cargill et al., 1999). Where an allele which was
obviously the major allele in Homo sapiens (this study and
sequences used as references) was not in agreement with that
of the Pan troglodytes sequences at the same position, the former
was selected as WT. This was the case for the indels, CTAT/–, AG/–
and ACAA/G where published sequences for Pan troglodytes, some
of the Homo sapiens reference sequences, as well as data for SAC
would indicate the minor allele contained nucleotide insertions at
these indel positions, yet overall themost frequent alleles detected
in this study indicated that the minor allele for all 3 indel positions
was the allele containing nucleotide deletions at those positions.
The same was observed for SNPs 2852A/G and 113G/T, where
the Pan troglodytes base at that position was the equivalent of the
minor allele/nucleotide in humans. The minor allele frequencies of
the CCR5 SNPs and indels in both the study populations are shown
in Table 1.
Of the polymorphisms detected within the CCR5 ORF, one has
not been reported previously (Table 1). This novel SNP (+258G/C)
within the ORF leads to a non-synonymous amino acid change
(Trp! Cys) at codon 86 and was detected in one SAC individual
heterozygous for that mutation. Four mutations in the open
reading frame were detected in the SAA population: +225T/C;
+319C/T; +673C/T and +1004C/T (S75S; L107F; R225X and A335 V,
respectively). One individual was found to be heterozygous for
previously described mutations at both codon 107 and 225
(Petersen et al., 2001). In a study conducted by Petersen et al.
(2001), these two mutations were reported as occurring simulta-
neously in an individual and at low frequencies in SAA and South
African Coloureds. The codon 335 amino acid substitution
mutation was detected within the SAA population at a frequency
of 0.071 (n = 5) and only one individual in the SAC population was
found to harbour this mutation (Table 1). Previous reports looking
at African American (Ansari-Lari et al., 1997; Carrington et al.,
1997; Carrington et al., 1999) and SAA (Petersen et al., 2001)
populations found the mutation present at a frequency of
approximately 3% and 2%, respectively. Although representation
of this SNP appears higher (7.1%) in our study, this did not differ
statistically from frequencies reported in these studies (P > 0.05).
Several polymorphisms were found to be restricted to either
the SAA or the SAC population group (frequencies highlighted in
Table 1
Frequencies of identiﬁed polymorphisms within the SAA and SAC study populations.
Location on gene SNP position Base change (wt/mut) Accession numbera n (population frequency)b
SAAc SACc
50 UTR (2762bp) 5268 G/A rs3136535 3 (0.043) 6 (0.086)
5266 G/A rs6776227 3 (0.043) 0
5214 T/C NI 1 (0.014) 0
5080 T/A rs41429449 4 (0.057) 0
5072 C/T rs35078594 4 (0.057) 0
4897 G/A NI 0 1 (0.014)
4808 G/A NI 2 (0.029) 6 (0.086)
4745 C/T rs3136536 9 (0.129) 0
4630 T/C NI 0 1 (0.014)
4358 A/G rs7637813 2 (0.029) 16 (0.229)
4257 A/C rs41490645 0 6 (0.086)
4223 C/T NI 4 (0.057) 0
4088 T/C rs41499550 14 (0.200) 0
3949 A/G NI 0 1 (0.014)
3899 A/C rs72622924 10 (0.143) 42 (0.600)
3894 T/C rs41395049 14 (0.200) 0
3886 C/T NI 0 3 (0.043)
3868 CTAT/– rs10577983 10 (0.143) 40 (0.557)
3833 C/T NI 1 (0.014) 0
3458 G/T rs2734225 9 (0.129) 39 (0.557)
3432 T/C NI 1 (0.014) 0
3261 G/A rs41475349 14 (0.200) 0
2852 A/G rs2227010 19 (0.271) 25 (0.357)
2823 T/A NI 1 (0.014) 0
Exon 1 (57bp) 2733 A/G rs2856758 3 (0.043) 7 (0.100)
Intron 1 (501bp) 2577 T/G NI 1 (0.014) 0
2554 G/T rs2734648 22 (0.314) 39 (0.557)
2459 G/A rs1799987 30 (0.429) 28 (0.400)
2454 G/A NI 3 (0.043) 1 (0.014)
Exon 2A (235bp) 2150 A/G NI 1 (0.014) 0
2135 T/C rs1799988 30 (0.429) 28 (0.400)
2132 C/T rs41469351 13 (0.186) 0
2086 A/G rs1800023 9 (0.129) 39 (0.557)
2048 C/G rs41355345 0 1 (0.014)
Intron 2 (1903bp) 1835 C/T rs1800024 11 (0.157) 3 (0.043)
1686 A/C rs9282632 17 (0.243) 0
1464 A/G rs3181037 17 (0.243) 0
1193 C/T NI 1 (0.014) 0
1130 AG/– rs3054375 9 (0.129) 39 (0.557)
1060 C/T rs2856762 0 3 (0.043)
976 C/T rs2254089 9 (0.129) 39 (0.557)
975 G/A rs41395249 6 (0.086) 0
730 A/T NI 2 (0.029) 0
651 C/T rs2856764 9 (0.129) 39 (0.557)
451 C/T NI 3 (0.043) 1 (0.014)
444 G/A rs2856765/rs35046662 9 (0.129) 39 (0.557)
362 ACAA/G rs71619644 9 (0.129) 39 (0.557)
113 G/T rs3176763 17 (0.243) 0
112 G/A rs41352147 1 (0.014) 0
Exon 3/ORF (1059bp) +225 T/C rs1800941 1 (0.014) 0
+258 G/C NI 0 1 (0.014)
+319 C/T Petersen et al. (2001) 1 (0.014) 0
+554 D32 rs333 0 5 (0.071)
+673 C/T Petersen et al. (2001) 1 (0.014) 0
+1004 C/T rs1800944 5 (0.071) 1 (0.014)
30 UTR (2651bp) +1253 A/G NI 1 (0.014) 0
+1752 G/A rs41495153 18 (0.257) 0
+1810 G/A NI 1 (0.014) 0
+1823 C/T rs17765882 0 3 (0.043)
+1843 G/A rs41418945 9 (0.129) 0
+1846 G/A rs41466044 9 (0.129) 0
+2066 G/A NI 2 (0.029) 0
+2077 G/T rs1800874 9 (0.129) 37 (0.529)
+2225 T/C rs41535253 4 (0.057) 0
+2293 A/G rs41526948 0 1 (0.014)
+2381 A/G NI 1 (0.014) 0
+2435 T/A NI 1 (0.014) 0
+2458 A/C rs3188094 6 (0.086) 0
+2676 C/A rs41442546 0 6 (0.086)
+2772 G insertion NI 5 (0.071) 1 (0.014)
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Table 1 (Continued )
Location on gene SNP position Base change (wt/mut) Accession numbera n (population frequency)b
SAAc SACc
+2838 C/G rs41512547 3 (0.043) 0
+2919 T/G rs746492 28 (0.400) 27 (0.386)
+3132 T/G NI 0 1 (0.014)
a Accession numbers of SNPs detected in this studywhich have been previously reported in the SNP database (dbSNP) or reference to report not in database are listed here;
NI indicates newly identiﬁed polymorphisms not found in dbSNP.
b Frequency was calculated for both populations using total number of alleles, i.e., n=70.
c Grey shading highlights polymorphisms which were found to be restricted to either the SAA or the SAC population group.
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1686A/C, 1464A/G, 113G/T and +1752G/A, are all restricted
to the SAA population at a frequency of >18% and all form part of
the putative haplotypes, SAA-HHA and SAA-HHD, identiﬁed in
this study. In addition, the SNPs, 4745C/T, +1843G/A and
+1846G/A, were detected at a reasonably high frequency of 12.9%
in SAA individuals but not in SAC individuals. There were no SNPs
found exclusively in the SAC population which were also present
at relatively high frequencies (i.e., at a frequency >10%) in that
population. Where the SNP frequency is low in one population,
absence in the other population cannot be used to state that that
particular SNP is only prevalent in one population due to the
sample size used in this study.
3.2. Indels
Five indels were detected across the entire CCR5 gene (Fig. 1).
Four of the ﬁve detected indels have been previously described
(Dean et al., 1996; Samson et al., 1996; Mummidi et al., 1997). The
D32 deletion indel was found in 5/35 (14.3%) SAC individuals, all of
which were heterozygous for this mutation, but not in SAA
individuals. In a previous South African study, the CCR5D32 allele
was detected at a frequency of 9.4% and 0.1% in SAC and SAA
individuals, respectively (Williamson et al., 2000). Comparison of
CCR5D32 allele frequencies observed in SAC populations in the two
studies showed no signiﬁcant difference between them (P = 0.68).
The other three previously reported deletion indels (CTAT/–, AG/–
and ACAA/G) appear to be in very strong linkage disequilibrium
(D0 = 1.0, P < 0.0005 for all three indel associations in both
population groups).
Two indels are located within Intron 2 of the CCR5 gene. The
indel located at position 362 has been reported differently. In a
report characterizing the CCR5 gene this is shown to be a CAA indel
(Mummidi et al., 1997). Within the dbSNP database there are two
polymorphism reports for that location: accession number
rs41515644 reports an A/G SNP at that position, whereas accession
number rs71615644 reports that the four nucleotide sequence,
ACAA, is substituted with a single guanine nucleotide. Within our
study group, only the latter polymorphism was observed. The
Intron 2 PCR amplicons from two individuals heterozygous for the
ACAA indel were cloned and sequenced. Sequencing demonstrated
that on the alleles where there was a ACAA deletion, there would
be a G substitution at that point. Thus, in our report, the deletion
and base substitution have been treated as a single polymorphism.
It is possible though that the ACAA/G indel may have arisen as two
separate events which became evolutionarily linked, i.e. an A to G
substitution and a CAA deletion immediately downstream from
the substitution.
The indel downstream from the open reading frame (Fig. 1)
consists of a single guanine insertion. Alleles containing the indel
have a string of nine guanine bases in that region, whereas the WT
alleles have eight guanine nucleotides. The exact position of the
single base insertion within the eight consecutive guanine bases of
the WT sequence cannot be precisely determined. Thus, theposition of +2772, at the end of the eight guanine bases has been
selected.
3.3. Haplotypes
Individualswithin the SAAandSACpopulationswere assigned to
previously described haplogroups (Gonzalez et al., 1999) based on
SNPs at positions2733,2554,2459,2135,2132,2086 and
1835 as well as the presence of CCR5D32 (Fig. 2A). One SAA
individualwas foundtobeheterozygous forahaplotypeallelewhich
could not be classed into any of the haplotypes deﬁned byMartin et
al. (1998) or Gonzalez et al. (1999). Similar trends in haplotype
frequency to that reported in a larger study conducted by Gonzalez
et al. (1999, 2001) were observed. In SAC, HHA appears to be
underrepresented (4.3% vs. 10% reported in Caucasians (Gonzalez et
al., 2001)) and HHC as overrepresented (55.7% vs. 35% in Caucasians
(Gonzalez et al., 2001)) and in SAA, HHF appears underrepresented
(15.7% vs. 24% reported in African non-pygmies (Gonzalez et al.,
2001)) and HHG*1 overrepresented at 4.3% (2% reported in African
non-pygmies (Gonzalez et al., 2001)). Fisher exact test shows
signiﬁcant difference in HHC frequencies (P = 0.005) but no
signiﬁcant difference in the HHF, HHG*1 and HHA frequencies
between the two studies (P > 0.05). The overrepresentation of HHC
haplotype frequency in the SAC population in this study could
potentially be attributed to differences in Caucasian population
ancestry in the twostudies. In the largerGonzalezet al. (2001) study,
their Caucasian study group (n = 959) is comprised of HIV-1
uninfected individuals from Finland, France and Poland and
European American individuals of mixed infection status (i.e. both
HIV-positive and HIV-negative individuals) (Gonzalez et al., 2001).
Another possible explanation would be the presence of a greater
amount of admixture within the Caucasian study group in the
Gonzalez et al. (2001) study. These previously deﬁned haplotypes
however are located in a relatively small region of the CCR5 gene
(898 bp of the regulatory region of CCR5, in addition to presence/
absence of CCR5D32 in ORF and CCR2 V64I upstream on the same
chromosome). This study has identiﬁed putative haplotypes which
extend over the entire gene in both directions.
Seven complex putative haplotypes spanning the length of the
sequenced region have been identiﬁed (Fig. 2B). These haplotypes
appear to be extensions of haplotypes previously described within
CCR5 (Gonzalez et al., 1999) (HHA, HHC, HHD, HHE and HHG*2).
Haplotypes were named by preﬁxing the root haplotype name
with the population within which it was found. Thus, a distinction
can be made when haplotypes with the same root differ in SNP
composition between study population groups (e.g. SAA-HHE and
SAC-HHE which are both rooted on the HHE haplotype but differ
between SAA and SAC individuals bearing the HHE haplotype).
Where haplotypes were found to be identical in both study
populations, the preﬁx SAA/C– was used. All the haplotypes
described in this study occurred at a frequency greater than 5% and
one was found at a frequency of 52.9% (SAA/C–HHC in SAC
individuals). Five predominant putative haplotypes were identi-
ﬁed in the SAA population whereas only three were identiﬁed in
Fig. 2. (A) Schematic representation of haplotypes previously deﬁned by Gonzalez et al. (1999) and the frequency at which they were detected within our two study
populations. (B) Haplotypes identiﬁed within the CCR5 gene in the SAA and SAC study populations. Haplotypes were named by preﬁxing the root haplotype with the
population within which it was found. Polymorphic positions as well as the wild type (WT) to mutant change are shown. Coloured boxes indicate SNPs or indels which form
part of the haplotype and the frequency of occurrence in that particular population group is indicated. The root haplotype (Gonzalez et al., 1999) is also indicated.
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shared by both study populations. This haplotype, SAA/C–HHC, is
comprised of three indels and eight SNPs and is the most frequent
haplotype in SAC individuals (52.9%) and the least frequent in SAA
individuals (8.6%) (Fig. 2B).
Linkage disequilibrium analysis between every two SNP
combination in haplotypes identiﬁed in this study demonstrated
strong linkage disequilibrium between SNPs with a statistical
signiﬁcance greater than 95%.
All HHA, HHF, HHG*2 and HHD haplotypes were found to be
associated with further SNPs, forming haplotypes SAA-HAA, SAA-
HHF, SAC-HHG*2 and SAA-HHD, respectively (Fig. 2B). Themajority
of HHC and HHE alleles are associated with further SNPs forming
SAA/C–HHC, SAC-HHE and SAA-HHE. SAC-HHE and SAA-HHE are
two putative haplotypes rooted on the HHE haplotype but differ at
the inclusion of an additional SNP (4358A/G) in SAC-HHE. The
corresponding haplotypes occur at similar frequencies in the two
populations (SAC-HHE: 18.6% in SAC and SAA-HHE: 20% in SAA).
All 13 alleles (SAA) classed as HHD can also be classed as SAA-
HHD. Hence, a further three polymorphisms 4088T/C; 3894T/C
and 3261G/A) can be said to be associated with the HHD
haplotype (D0 = 1.0, P < 0.0005, for all SNP associations within the
haplotype). No HHD haplotypes were found in the SAC population.
HHF haplotypes appear to be linked to the +2919T/G SNP forming
SAA-HHF.
In the SAC population 37/39 alleles classed as haplotype HHC,
could also be classed as the HHC extended haplotype, SAA/C–HHC,
by far themost predominant haplotype in that population (Fig. 2B).
The remaining 2 HHC-bearing alleles occurred in two individuals
homozygous for ten of the eleven polymorphism sites comprising
SAA/C–HHC and were heterozygous for the +2077T/G SNP. Six out
of eight HHC alleles in the SAA population exhibit the SAA/C–HHC
polymorphism pattern, one allele lacks the SNP at position +2077
and the other lacks the SNP at 3458.
The HHA haplotype, which comprises WT bases at all SNPs
positions used in the Gonzalez et al. (1999) classiﬁcation system, ispresent at a frequency of 24.3% and 4.3% in the SAA and SAC
populations, respectively (Fig. 2A). Although this may appear to
imply that individuals harbouring the HHA haplotype are WT
across the entire CCR5 gene, this is not the case as the HHA
haplotype appears to be associated with different SNPs in the
extended haplotypes in the different populations (Fig. 2B). In SAA
individuals, HHA is associated with SNPs: 1686A/C, 1464A/G;
113G/T and +1752G/A forming SAA-HHA, whereas in SAC HHA
alleles demonstrate no association with those SNPs but are instead
linked in a haplotype to C/T SNPs at positions 3886; 1060 and
+1823, all of which are polymorphisms not detected within the
SAA study group. It must be noted, however, that in the SAC
population this is a rare haplotype (4.3%) and so has not been
shown as one of the predominant haplotypes in Fig. 2B and caution
must be taken in assuming this is a true association.
The haplotype HHG can be subdivided into HHG*1 (alleles not
containingD32 deletion in ORF) and HHG*2 (alleles containingD32
deletion inORF). All HHG*2 haplotypes detected in this study (n = 5)
were found to contain an additional three SNPs (5268G/A,
4257A/C and +2919T/G), forming SAA-HHG*2 (Fig. 2B). The two
SAC-HHG*1alleleswere identical toSAA-HHG*2withone individual
lacking the +2919T/G polymorphism. In contrast, the three SAA-
HHG*1 alleles only had the additional polymorphisms, 5268G/A
and 2852A/G, in common with the SAA-HHG*2 haplotype.
3.4. Hardy–Weinberg equilibrium
No signiﬁcant deviations from Hardy–Weinberg equilibrium
were noted for any of the indels or SNP loci detected in this study in
both the SAA and SAC population groups.
4. Discussion
In this study we have characterized polymorphisms (SNPs and
indels) and intragenic haplotypes found within CCR5 for two South
African populations, SAA and SAC. This provides a baseline study
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two populations. Previously unreported polymorphisms have been
identiﬁed and previously deﬁned haplotypes within the CCR5 gene
have been expanded upon.
There exists greater genetic diversity and low levels of linkage
disequilibrium within African populations in comparison to
European-originating populations (Tishkoff and Verrelli, 2003;
Tishkoff et al., 2009). Hence, it is not unexpected to have found a
greater number of polymorphisms in SAA in comparison to SAC
individuals, as alsoobserved ina recent study reportedbyPaximadis
et al. (2009). Full length sequencing of the CCR5 gene allows for
identiﬁcation of SNPs which would normally not be detected.
Although a number of NI SNPs were identiﬁed in our study
population, these may have been missed in previous studies which
look at a smaller portion of the gene or which use other means of
identifying speciﬁc polymorphisms. Also, most of the NI poly-
morphisms identiﬁed in this study were detected exclusively in the
SAApopulation. Owing to the sample sizes in this study, detection of
a SNP in only one of the two study population groups cannot beused
to conclude that that SNP is absent in the other population, but it can
be used as an indication of overall prevalence and diversity.
At SNP positions where the major allele (WT) in our study and
that of other human reference sequences differed from that of the
chimpanzee sequence, the chimpanzee sequence was found to
correspond to theminor allele in humans (CTAT/–, AG/– and ACAA/
G indels as well as 2852A/G and 113G/T SNPs). In a study
characterizing the SNPs in 106 human genes, Cargill et al. (1999)
noted that in a signiﬁcant fraction of cases, the minor chimpanzee
allele had become the major human allele and hence the minor
human allele was in fact the older allele. This has also been
observed in a study reporting variants in the CCL3 and CCL3L genes
which code for CCR5 ligands (Paximadis et al., 2009).
The codon 335 mutation resulting in an alanine to valine
(A335V) substitution was previously reported by Ansari-Lari et al.
(1997) and has been found to be present at a higher frequency in
African American populations in comparison to Caucasians
(Ansari-Lari et al., 1997; Carrington et al., 1997; Carrington et
al., 1999). Although this mutation occurs in the ORF and could be
thought to potentially affect protein structure and/or function, in a
disease association study, this mutation has been found to have no
effect on the rate of progression to AIDS (Carrington et al., 1997). In
a study conducted in South African populations, the A335V
mutation was detected in African and Coloured populations but
not in Caucasians (Petersen et al., 2001). Our study indicates that
this mutation is in fact present in the SAC population but as a very
rare polymorphism (only 1/35 individuals harboured this allele). In
SAA individuals, this mutation was detected at a much higher
frequency than that reported elsewhere (Ansari-Lari et al., 1997;
Carrington et al., 1997, 1999; Petersen et al., 2001). However,
comparison of A335V mutation frequencies in SAA individuals
from this study to that of healthy SAA individuals in another South
African study (Petersen et al., 2001) indicated no signiﬁcant
difference between observed frequencies (7.1% vs. 1.6%; P = 0.099).
This and the Petersen et al. (2001) study were conducted in two
widely separated geographical regions within South Africa, the
Gauteng and Western Cape provinces, respectively.
A novel non-synonymous mutation has been detected within
the ORF at codon 86. It is unclear whether this tryptophan to
cysteine amino acid substitution will have an impact on
chemokine-receptor function. Amino acid alignment of chemokine
receptors, CCR5, CCR2B, CCR1, CCR3, CCR4 and CXCR4 (Carrington
et al., 1997) shows that this mutation occurs within a highly
conserved region (second transmembrane region) between the
receptors at a point where all aligned proteins contain a
tryptophan residue. This high level of conservation implies that
this region is important to the structure or function of the proteinand hence indicates that the signiﬁcance of this novel mutation
warrants further study. Both tryptophan and cysteine residues are
hydrophobic molecules but cysteine is considerably smaller than
tryptophan. Also, tryptophan residues positioned near lipid
bilayers, as with residue 86, tend to form hydrogen bonds with
the lipid head groups (Schiffer et al., 1992) whereas cysteine
residues are likely to form disulphide bonds. Thus, it is possible
that this amino acid change may have an impact on the folding of
the peptide chain and hence its function as a receptor.
Several SNPs located in the CCR5 promoter have been
previously reported to affect the expression of CCR5. One such
polymorphism is the 2459G/A polymorphism located within the
downstream promoter (P1). This polymorphism has been linked to
differences in CCR5 expression levels on CD14+ monocytes
(Salkowitz et al., 2003) and has known association with the rate
of progression to AIDS (McDermott et al., 1998). Individuals
homozogous for the 2459G allele exhibit lower CCR5 receptor
density in CD14+ monocytes (Salkowitz et al., 2003) and have been
linked to slower disease progression (McDermott et al., 1998;
Clegg et al., 2000; Knudsen et al., 2001). Both WT and mutant
alleles have been found to be present at high frequencies in all
racial groups, with reported frequencies of 43% and 57% in African
and Caucasian populations, respectively (McDermott et al., 1998).
In this study, the 2459A allele was detected at a frequency of
42.9% and 40.0% in SAA and SAC population groups, respectively.
Fisher exact analysis of the frequencies observed in the two studies
has shown no statistical difference between the African population
(P = 1.0) but there was a statistical difference between the
Caucasian populations (P = 0.0083). This is not unexpected as
the WT alleles, 2459G and 2135T, which are in very strong
linkage disequilibrium with each other (Gonzalez et al., 1999;
Clegg et al., 2000), form part of the SAA/C–HHC haplotype which
was present at a higher than expected frequency in the SAC
population. Thus, it follows that the minor/mutant alleles at those
positions will also be underrepresented. These two SNPs form part
of the HHE, HHF and HHG haplotypes deﬁned by Gonzalez et al.
(1999) and the predominant putative haplotypes, SAC-HHE and
SAC-HHG*2 described in the SAC population.
Although studies looking at individual polymorphisms on
susceptibility to HIV-1 infection and the rate at which individuals
progress to AIDS, do provide useful information, it is not always
possible to pinpoint the cause of the observed effect of a particular
polymorphism when studying the regulatory region of the gene as
different combinations of polymorphisms may be in linkage
disequilibrium forming haplotypes. Thus, it is important to look at
haplotypes and their prevalence across the breadth of a gene.
When examining the effects of CCR5 haplotypes on HIV-1
disease in different population groups, Gonzalez et al. (1999)
observed that haplotype diversity is greatest in African popula-
tions. This was also reﬂected in our study where ﬁve major
(frequency >5%) haplotypes were observed in SAA individuals,
whereas only three were found in SAC individuals.
In this report there are a number of polymorphisms where the
minor allele in the SAA population has been shown to be the
predominant or ‘major’ allele in the SAC population. This is most
evident with the SNPs comprising the SAA/C–HHC haplotype.
While SAA/C–HHC, and hence its associated polymorphisms, is by
far the most prevalent haplotype detected in the SAC population
(52.9%), in the SAA population this haplotype is much less
prevalent (8.6%). The most prevalent haplotype in the SAA
population is SAA-HHA which is an extension of the HHA
haplotype reported to be the ancestral CCR5 haplotype (Mummidi
et al., 2000). This is likely to be due to different evolutionary
pressures being exerted on the two populations or a genetic
bottleneck where a signiﬁcant number of members of one the
populations was unable to reproduce.
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(Martin et al., 1998; Gonzalez et al., 1999). Martin et al. (1998)
described 10 haplotypes, CCR5P1–P10, comprising 10 SNP posi-
tions within the region starting at Exon 1 and ending in Exon 2B of
the gene. The nine haplotypes described by Gonzalez et al. (1999)
comprise seven SNP positions within a similar region but
extending slightly into Intron 2, the presence/absence of CCR5D32
in addition to the CCR2-64I mutation. In this study we have
expanded upon this and have linked previously deﬁned haplotypes
to SNPs both upstream and downstream of these regions forming
haplotypeswhich extend over a larger region of the genewith SNPs
linked in a haplotype being as much as 8.1 kb apart (SNP
positions 5248 and +2919 in Hap-D32).
A better understanding of the role played by host genes in
response to human immunodeﬁciency virus (HIV-1) exposure will
contribute towards a better understanding of the protective
immunity to HIV-1 and of the disease process in HIV-1-infected
individuals. CCR5 is increasingly being shown to play a critical and
central role in HIV-1 infection and to date a number of genetic
mutations within the gene have been found to positively or
negatively inﬂuence an individual’s susceptibility and rate of
disease progression. Thus, studies such as these which provide
valuable new information regarding the genetic diversity within
this gene, are important to the further understanding of the impact
of CCR5 expression on host susceptibility to HIV-1.
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